Replies to post #104173 on Anavex Life Sciences Corp (AVXL)

[baltimorebullet]

I was not aware one could try drugs on people as they please.

And if they did, as a publicly traded company, aren't they obligated to inform us of so important a thing? Does this mean they could run a pretest of Ariana's crunched numbers?

[roygbiv]

It sure does sound like it to me. International patent law is not my strong suit.

During Obama's press conference after the passage of 21st Century Cures he mentioned both AD and Epilepsy together and precision medicine not far behind. Perhaps the Doc has positioned us in the sweet spot and is going to bring good tidings of great joy to many in need!

A19-1144 is A2-73's metabolite. Have not heard much about A1-41 other then it was the second lead compound to be announced by the company. Seems as though A3-71 has slipped into its place.

About ANAVEX 1-41

ANAVEX 1-41 is a selective ligand for sigma-1 receptors. Selective ligands have fewer adverse effects than non-selective ligands because they do not bind to several other receptors in addition to the one that generates the desired effect. ANAVEX 1-41 has exhibited evidence as an anti-depressive, anti-amnesic, anti-convulsive and neuroprotective agent in animal models.

http://www.anavex.com/anavex-advances-second-lead-compound-initiates-scale-up-manufacturing-of-anavex-1-41/

Make it rain!

[baltimorebullet]

Apologies Xena.

This was a brief 3 way discussion with Bourbon back in May and it was in regard to epilepsy not MS.